Middle cerebral artery mean flow velocity at three time points. by Marco Carbonara (11483575)

Subjects:

Optic Nerve Sheath Diameter (ONSD) in mm, measured by ultrasound. by Marco Carbonara (11483575)

Subjects:

ONSD at T14 and six months after ICU discharge. by Marco Carbonara (11483575)

Subjects:

Bland-Altman plot indicating the agreement between the optic nerve sheath diameter measured with CT scan and US. by Marco Carbonara (11483575)

Subjects:

The demographical and clinical characteristics of subjects at baseline. by Sadaf Sepasgozar Sarkhosh (20436143)

ALK inhibitors (Positive control) and ABT199 (Proposed binding) in complex with the ALK active side. by Richard Junior Zapata Dongo (17912565)

Elevated concentrations of serum MMA among participants with decreased cognitive performance. by Yige Liu (11940344)

Patellar 3D-MRI before and after OWHTO in all cases. by Yusuke Fuchioka (22806178)

Subjects:

Distribution of patients in the 4 age groups, mean value of IC-volume from both sides and separately for the left and right ICs. by Pingling Kwok (14896191)

Subjects:

Demographics of the study population. by Sohyun Park (78358)

“…In the comparison among the ipsilateral, contralateral side of iPD with clinical laterality, and disease control group, the OBH of the disease control group was significantly larger than both the ipsilateral and contralateral sides (<i>P</i> < 0.05). …”

Table 3 - by Sohyun Park (78358)

“…In the comparison among the ipsilateral, contralateral side of iPD with clinical laterality, and disease control group, the OBH of the disease control group was significantly larger than both the ipsilateral and contralateral sides (<i>P</i> < 0.05). …”

The demographical and clinical characteristics of subjects at baseline. by Soheila Qanbari (20455173)

Subjects:

The mean and standard deviation of parameters. by Sadaf Sepasgozar Sarkhosh (20436143)

“…Results indicated a significant decrease in ML SI in both groups one month after treatment compared to before and after treatment (P = 0.013 and P<0.001, respectively). …”

The ANCOVA and Post_hoc results. by Sadaf Sepasgozar Sarkhosh (20436143)

“…Results indicated a significant decrease in ML SI in both groups one month after treatment compared to before and after treatment (P = 0.013 and P<0.001, respectively). …”

CONSORT flowchart. by Sadaf Sepasgozar Sarkhosh (20436143)

“…Results indicated a significant decrease in ML SI in both groups one month after treatment compared to before and after treatment (P = 0.013 and P<0.001, respectively). …”

Time to stabilization in the vertical direction. by Sadaf Sepasgozar Sarkhosh (20436143)

“…Results indicated a significant decrease in ML SI in both groups one month after treatment compared to before and after treatment (P = 0.013 and P<0.001, respectively). …”

The description of games. by Sadaf Sepasgozar Sarkhosh (20436143)

“…Results indicated a significant decrease in ML SI in both groups one month after treatment compared to before and after treatment (P = 0.013 and P<0.001, respectively). …”

The description of balance training. by Sadaf Sepasgozar Sarkhosh (20436143)

“…Results indicated a significant decrease in ML SI in both groups one month after treatment compared to before and after treatment (P = 0.013 and P<0.001, respectively). …”

The flow-diagram for the randomised clinical study. by Iva Milinkovic (22331710)

Subjects:

Decreased clonogenic capacity of U87MG and U251MG GB cells following treatment with SHG-44 and cis-platin at equal concentrations. by Denis Mustafov (19137870)